Candriam Equities L Oncology Impact R/ LU1864482788 /
| NAV2024-04-30 | Chg.-1.4000 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 273.2300USD | -0.51% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | - | - | - | - | - | - | - | - | - | - | - | -6.01 | - |
| 2019 | 10.23 | 6.17 | 2.65 | -3.66 | -2.58 | 8.68 | 0.29 | -0.29 | -3.18 | 5.10 | 7.95 | 5.04 | +41.40% |
| 2020 | -1.47 | -5.35 | -3.08 | 12.11 | 8.53 | 1.41 | 4.42 | 2.15 | 3.51 | -2.22 | 5.80 | 3.86 | +32.31% |
| 2021 | 0.54 | -4.21 | -0.10 | 2.32 | 0.17 | 3.52 | -0.97 | 5.57 | -3.78 | 3.37 | -6.38 | 3.98 | +3.33% |
| 2022 | -10.50 | -1.76 | 4.64 | -5.86 | -1.34 | 0.03 | 4.36 | -3.15 | -4.72 | 7.04 | 6.06 | -3.45 | -9.77% |
| 2023 | 2.15 | -3.89 | 1.38 | 2.82 | -2.57 | 0.08 | 0.88 | -2.03 | -5.25 | -6.37 | 9.21 | 5.72 | +1.01% |
| 2024 | 1.36 | 4.13 | 1.49 | -3.39 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 11.12% | 11.88% | 11.83% | 14.75% | 17.31% |
| Sharpe ratio | 0.65 | 3.40 | -0.12 | -0.28 | 0.33 |
| Best month | +5.72% | +9.21% | +9.21% | +9.21% | +12.11% |
| Worst month | -3.39% | -6.37% | -6.37% | -10.50% | -10.50% |
| Maximum loss | -6.78% | -6.78% | -16.46% | -25.23% | -25.23% |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,286.1599 | +2.84% | +0.26% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,442.7600 | +2.97% | +0.63% | |
| Candriam Equities L Oncology Imp... | reinvestment | 198.3500 | -0.60% | -10.04% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,170.2200 | +2.01% | +9.81% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,534.5200 | +2.51% | -0.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 237.7400 | +4.28% | +8.68% | |
| Candriam Equities L Oncology Imp... | paying dividend | 225.1200 | +1.55% | -3.45% | |
| Candriam Equities L Oncology Imp... | paying dividend | 182.2200 | +2.42% | -0.99% | |
| Candriam Equities L Oncology Imp... | paying dividend | 19,992.0000 | -0.45% | -2.73% | |
| Candriam Equities L Oncology Imp... | reinvestment | 153.5400 | +1.89% | +9.43% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,015.7000 | +0.34% | -7.46% | |
| Candriam Equities L Oncology Imp... | reinvestment | 251.7900 | +5.16% | +11.46% | |
| Candriam Equities L Oncology Imp... | reinvestment | 197.9000 | -0.99% | -11.09% | |
| Candriam Equities L Oncology Imp... | reinvestment | 273.2300 | +2.41% | -1.00% | |
| Candriam Equities L Oncology Imp... | reinvestment | 185.1400 | +0.23% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,789.7600 | +2.33% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,746.7000 | +2.51% | -0.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 152.8800 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 261.5600 | +1.56% | -3.47% |
Performance
| YTD | +3.48% | ||
|---|---|---|---|
| 6 Months | +20.06% | ||
| 1 Year | +2.41% | ||
| 3 Years | -1.00% | ||
| 5 Years | +57.54% | ||
| Since start | +82.15% | ||
| Year | |||
| 2023 | +1.01% | ||
| 2022 | -9.77% | ||
| 2021 | +3.33% | ||
| 2020 | +32.31% | ||
| 2019 | +41.40% | ||
